BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12352913)

  • 41. Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation.
    van den Berg AP; Klompmaker IJ; Haagsma EB; Scholten-Sampson A; Bijleveld CM; Schirm J; van der Giessen M; Slooff MJ; The TH
    J Infect Dis; 1991 Aug; 164(2):265-70. PubMed ID: 1649873
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients.
    Toyoda M; Carlos JB; Galera OA; Galfayan K; Zhang X; Sun Z; Czer LS; Jordan SC
    Transplantation; 1997 Apr; 63(7):957-63. PubMed ID: 9112347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring of human cytomegalovirus, HHV-6 and HHV-7 infection in kidney transplant recipients by molecular methods to predict HCMV disease after transplantation: a prospective study.
    Rayes N; Seehofer D; Lullius SG; Stein A; May G; Kahl A; Frei U; Neuhaus P; Meisel H
    Ann Transplant; 2005; 10(2):23-8. PubMed ID: 16218029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospective study on CMV-reactivations under preemptive strategy in CMV-seropositive adult liver transplant recipients.
    Lautenschlager I; Loginov R; Mäkisalo H; Höckerstedt K
    J Clin Virol; 2013 May; 57(1):50-3. PubMed ID: 23403239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation.
    Sia IG; Wilson JA; Groettum CM; Espy MJ; Smith TF; Paya CV
    J Infect Dis; 2000 Feb; 181(2):717-20. PubMed ID: 10669361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation.
    Kijpittayarit S; Eid AJ; Brown RA; Paya CV; Razonable RR
    Clin Infect Dis; 2007 May; 44(10):1315-20. PubMed ID: 17443468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis.
    Roblin X; Pillet S; Oussalah A; Berthelot P; Del Tedesco E; Phelip JM; Chambonnière ML; Garraud O; Peyrin-Biroulet L; Pozzetto B
    Am J Gastroenterol; 2011 Nov; 106(11):2001-8. PubMed ID: 21788989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Congenital cytomegalovirus infection in twin pregnancies: viral load in the amniotic fluid and pregnancy outcome.
    Lazzarotto T; Gabrielli L; Foschini MP; Lanari M; Guerra B; Eusebi V; Landini MP
    Pediatrics; 2003 Aug; 112(2):e153-7. PubMed ID: 12897321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection and monitoring of cytomegalovirus infection in renal transplant patients by quantitative real-time PCR.
    Madi N; Al-Nakib W; Mustafa AS; Saeed T; Pacsa A; Nampoory MR
    Med Princ Pract; 2007; 16(4):268-73. PubMed ID: 17541291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CMV antigenemia and quantitative viral load assessments in hematopoietic stem cell transplant recipients.
    Cardeñoso L; Pinsky BA; Lautenschlager I; Aslam S; Cobb B; Vilchez RA; Hirsch HH
    J Clin Virol; 2013 Feb; 56(2):108-12. PubMed ID: 23146665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of a standardised real-time PCR based DNA-detection method (Realstar®) in whole blood for the diagnosis of primary human cytomegalovirus (CMV) infections in immunocompetent patients.
    Berth M; Benoy I; Christensen N
    Eur J Clin Microbiol Infect Dis; 2016 Feb; 35(2):245-9. PubMed ID: 26661089
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus-seropositive donor allografts.
    Singh N; Wannstedt C; Keyes L; Mayher D; Tickerhoof L; Akoad M; Wagener MM; Cacciarelli TV
    Liver Transpl; 2008 Feb; 14(2):240-4. PubMed ID: 18236404
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytomegalovirus (CMV) Monitoring After Liver Transplantation: Comparison of CMV Pp65 Antigenemia Assay with Real-Time PCR Calibrated to WHO International Standard.
    Kamei H; Ito Y; Onishi Y; Suzuki M; Imai H; Kurata N; Hori T; Tainaka T; Uchida H; Ogura Y
    Ann Transplant; 2016 Mar; 21():131-6. PubMed ID: 26927444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytomegalovirus load at treatment initiation is predictive of time to resolution of viremia and duration of therapy in hematopoietic cell transplant recipients.
    Tan SK; Waggoner JJ; Pinsky BA
    J Clin Virol; 2015 Aug; 69():179-83. PubMed ID: 26209403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early viral-specific T-cell testing predicts late cytomegalovirus reactivation following liver transplantation.
    Sood S; Haifer C; Yu L; Pavlovic J; Gow PJ; Jones RM; Visvanathan K; Angus PW; Testro AG
    Transpl Infect Dis; 2018 Oct; 20(5):e12934. PubMed ID: 29809312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
    Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
    J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Utility of cytomegalovirus viral load in renal transplant patients in Argentina.
    Mas V; Alvarellos T; Albano S; de Boccardo G; Giraudo C; Garrett CT; Ferreira-Gonzalez A
    Transplantation; 1999 Apr; 67(7):1050-5. PubMed ID: 10221492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation.
    Lochmanova A; Lochman I; Tomaskova H; Marsalkova P; Raszka J; Mrazek J; Dedochova J; Martinek A; Brozmanova H; Grundmann M
    Transplant Proc; 2010 Nov; 42(9):3574-7. PubMed ID: 21094818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of cytomegalovirus pp-65 antigenemia assay and plasma DNA correlation with the clinical outcome in transplant recipients.
    de Oña M; Melón S; Galarraga MC; Palacio A; Lambert JL; Bernardo MJ; Rodríguez M; Gómez E
    Transpl Int; 2005 Jan; 18(1):43-6. PubMed ID: 15612982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
    Sanghavi SK; Abu-Elmagd K; Keightley MC; St George K; Lewandowski K; Boes SS; Bullotta A; Dare R; Lassak M; Husain S; Kwak EJ; Paterson DL; Rinaldo CR
    J Clin Virol; 2008 Aug; 42(4):335-42. PubMed ID: 18495527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.